Androcur

Country of origin: Germany, Schering AG Germany, Schering AG/Schering GmbH and Co. Productions Germany, Schering S.A., a subsidiary of Schering AG France

Pharm-Group: Antiandrogens

Manufacturers: Salutas Fahlberg-List Pharma GmbH (Germany), Schering AG (Germany), Schering AG/Schering GmbH and Co. Productions (Germany), Schering S.A., a subsidiary of Schering AG (France)

International name: Cyproterone

Synonyms: Androkur-depot, Cyproterone-Teva

Dosage forms: 50 mg tablets, 10 mg tablets, 100 mg tablets

Composition: Active substance - Cyproterone.

Indications for use:

1. In men - hypersexuality, inoperable prostate carcinoma.

2. In women there are pronounced androgenization phenomena.

Contraindications: Liver diseases (Dubin-Johnson syndrome, Rotor, tumors), thromboembolic syndrome, depression, sickle cell anemia, idiopathic jaundice of pregnant women, herpes of pregnant women, pregnancy, breastfeeding.

Side effects: Changes in body weight, anxiety, fatigue, depression, decreased ability to concentrate, impaired liver function (at high doses). In men - suppression of spermatogenesis, gynecomastia. In women, there is a feeling of tension in the mammary glands. With rapid administration - cough, shortness of breath.

Interaction: No information.

Overdose: No information.

Special instructions:

1. During the treatment period, monitoring of liver function, adrenal cortex, and peripheral blood composition is necessary.

2. In patients with diabetes mellitus, dose adjustment of insulin and other glucose-lowering drugs is recommended.

3. In women, pregnancy should be excluded before starting treatment.

4. Alcohol consumption should be avoided.

5. During the treatment period, it is necessary to refrain from activities that require increased attention.

Literature: Encyclopedia of Medicines, 2003.